Skip to main content

Advertisement

Table 4 Prevalence of individual metabolic syndrome abnormalities in pregnant women with metabolic syndrome according to four definitions

From: Prevalence of metabolic syndrome in non-diabetic, pregnant Angolan women according to four diagnostic criteria and its effects on adverse perinatal outcomes

Components of MetS NCEPT–ATP III [5] N = 197 JIS MetS Criteria [6] N = 247 NCEPT–ATP III Bartha [10] modification N = 12 NHLBI/AHA Chatzi [8, 9] modification N = 85
Increased fasting glycemia ≥110 mg/dl 44 (22.3) ≥100 mg/dl 89 (36.0) ≥105 mg/dl 10 (83.3) ≥100 mg/dl 40 (47.1)
Obesity         
 BMI      >30 kg/m2 11 (91.7) >30 kg/m2 40 (47.1)
 Waist circumference >88 cm 189 (95.9) ≥80 cm 246 (99.6)   
Hypertriglyceridemia ≥150 mg/dl 166 (84.3) ≥150 mg/dl 199 (80.6) ≥270 mg/dl 1 (8.3) ≥150 mg/dl 78 (91.8)
Decreased HDL-C <50 mg/dl 45 (22.8) <50 mg/dl 49 (19.8) <40 mg/dl 2 (16.7) <50 mg/dl 32 (37.6)
Hypertension ≥130/85 mm/Hg 179 (90.9) ≥130/85 mm/Hg 216 (87.4) ≥130/85 mm/Hg 12 (100) ≥130/85 mm/Hg 79 (92.9)
Metabolic syndrome  %   29.2 (a)   36.6 (b)   1.8 (c)   12.6 (d)